Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy

NCT00860093 is registered in ClinicalTrials.gov with Mission Pharmacal as lead sponsor.

NCT NCT00860093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Lead sponsor
Mission Pharmacal
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2010
Completion date
December 31, 2010
Enrollment
135 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nephrolithiasis